StonvexLoading…
StonvexStonvexStonvexCore line items from JD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $187.20B | $158.76B | $152.77B | $151.69B |
Operating Income | $397.00M | $5.31B | $3.67B | $2.86B |
Net Income | $3.31B | $6.12B | $3.27B | $1.41B |
EPS (Diluted) | $0.92 | $1.84 | $1.07 | $0.47 |
Total Assets | $99.41B | $95.66B | $88.59B | $86.30B |
Total Liabilities | $57.40B | $52.74B | $46.84B | $46.56B |
Cash & Equivalents | $19.66B | $14.84B | $10.13B | $11.43B |
Free Cash Flow OCF − CapEx | $1.60B | $7.23B | $7.82B | $7.59B |
Shares Outstanding | 2.98B | 3.08B | 3.17B | 3.18B |